Clinical trial
Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject…
NCT00249834 · Merck KGaA, Darmstadt, Germany, Industry · Completed
Key facts
| NCT number | NCT00249834 |
|---|---|
| Title | Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF) |
| Official title | A Phase IIIB/IV, Open Label Study to Assess the Efficacy and Safety of a Pre-defined, Fixed Dose of Gonal-f® (Filled-by-Mass in a Prefilled Pen) Based on Subject Baseline Characteristics, for Ovarian Stimulation in Subjects Undergoing in Vitro Fertilization (IVF) |
| Acronym | CONSORT |
| Lead sponsor | Merck KGaA, Darmstadt, Germany, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug |
| Interventions | Gonal-f, Recombinant human chorionic gonadotrophin (r-hCG) |
| Enrollment | 166 |
| Start date | Sep 22, 2004 |
| Primary completion | Jan 16, 2006 |
| Completion | Jan 16, 2006 |
| First posted | Nov 7, 2005 |
| Last update posted | Mar 30, 2018 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: